Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)
This is a Phase Ib/IIa study to evaluate the safety and preliminary efficacy of Descartes-08
 CAR T-cells in patients with Generalized Myasthenia Gravis
Inclusion Criteria:

 -  Patient must be at least 18 years of age.

 -  Patient must have Generalized Myasthenia Gravis at the time of screening.

 -  Concomitant immunosuppressive drugs must be deemed necessary by the investigator.

 Exclusion Criteria:

 -  Major chronic illness that is not well managed at the time of study entry and in the
 opinion of the investigator may increase the risk to the patient.

 -  Patient is pregnant or lactating.